Head Of China's Sinopharm Seeks Foreign Acquisitions, Europe Focus
This article was originally published in PharmAsia News
Executive Summary
China's state-owned China National Pharmaceutical Group, a holding company that controls Sinopharm Group, is seeking foreign acquisitions, according to Chairman Song Zhiping.